Monthly migraine days, tablet utilization, and quality of life associated with Rimegepant – post hoc results from an open label safety study (BHV3000–201) - Johnston, Karissa; Harris, Linda; Powell, Lauren; Popoff, Evan; Coric, Vladimir; L’Italien, Gilbert; Schreiber, Curtis P. (Journal of headache and pain, 2022)
Keywords: Adult; Calcitonin Gene-Related Peptide Receptor Antagonists; CGRP; Double-Blind Method; Drug treatment; Drug use; Epidemiology; Headache; Humans; Internal Medicine; Medicine; Medicine & Public Health; Migraine; Migraine Disorders - drug therapy; Neurology; Pain management; Pain Medicine; Piperidines; Prescription drugs; Pyridines; Quality of Life; Research Article; Systematic review; Treatment Outcome; CGRP; Migraine; Drug treatment; Quality of life